Date published: 2025-11-24

00800 4573 8000

SCBT Portrait Logo
Seach Input

SLC17A2 Activateurs

Chemical activators of SLC17A2 can engage in various biochemical pathways to upregulate the protein's function. Verapamil, for instance, serves as a calcium channel blocker, leading to an increase in intracellular calcium levels, which is a key activator of SLC17A2, as it promotes the fusion of vesicles, an essential step in the protein's function. Similarly, the tyrosine kinase inhibitor Genistein can enhance SLC17A2 activity by preventing the dephosphorylation of proteins associated with it, thus maintaining SLC17A2 in a more active state. Forskolin, by increasing cAMP levels, indirectly stimulates SLC17A2 through the activation of protein kinase A, which can phosphorylate SLC17A2, thereby increasing its activity. Another agent, Phorbol 12-myristate 13-acetate (PMA), activates protein kinase C, which then phosphorylates SLC17A2, leading to enhanced activity of the protein.

Ionomycin functions by elevating intracellular calcium concentration, triggering calcium-dependent signaling pathways that activate SLC17A2. Monensin, an ionophore, alters intracellular ion concentrations, which in turn can activate SLC17A2 by modifying ion gradients that are crucial for the protein's activity. Brefeldin A disrupts the Golgi apparatus, causing SLC17A2 to redistribute to the plasma membrane where it becomes more active. N6-Cyclopentyladenosine, by stimulating adenosine A1 receptors, can enhance SLC17A2 activity through G protein-coupled receptor signaling pathways. Zinc Pyrithione increases the intracellular concentration of zinc, a metal ion that activates SLC17A2 through specific sensing pathways. Nicotinic Acid, as a precursor to NAD+, participates in redox reactions and energy metabolism that can lead to SLC17A2 activation. Guanfacine, an α2A-adrenergic receptor agonist, activates SLC17A2 through associated G protein-coupled receptor-mediated signaling. Lastly, Bay K 8644, as an L-type calcium channel agonist, directly increases calcium influx, which is a crucial activator of SLC17A2. Each of these chemicals, through their unique mechanisms, can serve to enhance the functional activity of SLC17A2 within cellular processes.

VOIR ÉGALEMENT...

Items  1  to  10  of  12 total

Afficher:

Nom du produitCAS #Ref. CatalogueQuantitéPrix HTCITATIONS Classement

Verapamil

52-53-9sc-507373
1 g
$367.00
(0)

Le vérapamil, un inhibiteur des canaux calciques, augmente les niveaux de calcium intracellulaire, ce qui active SLC17A2 en favorisant la fusion des vésicules.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

La génistéine, un inhibiteur de tyrosine kinase, renforce l'activité de SLC17A2 en inhibant la déphosphorylation des protéines associées, favorisant ainsi son état actif.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

La forskoline augmente les niveaux d'AMPc, ce qui active la protéine kinase A (PKA), et la PKA phosphoryle la SLC17A2, renforçant ainsi son activité.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

La PMA active la protéine kinase C (PKC) et la phosphorylation médiée par la PKC entraîne l'activation de la SLC17A2.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

L'ionomycine augmente la concentration de calcium intracellulaire, ce qui peut activer SLC17A2 par des voies de signalisation dépendantes du calcium.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$152.00
$515.00
(1)

La monensine agit comme un ionophore qui modifie les concentrations d'ions intracellulaires, activant ainsi SLC17A2 en modifiant le gradient ionique.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

La Brefeldine A perturbe la fonction de Golgi, ce qui peut conduire à la redistribution de SLC17A2 vers la membrane plasmique, augmentant ainsi son activité.

N6-Cyclopentyladenosine

41552-82-3sc-204117
50 mg
$120.00
2
(0)

Cet agoniste du récepteur de l'adénosine A1 peut renforcer l'activité du SLC17A2 par l'intermédiaire des voies de signalisation des récepteurs couplés à la protéine G.

Zinc

7440-66-6sc-213177
100 g
$47.00
(0)

La pyrithione de zinc peut augmenter la concentration intracellulaire de zinc, qui est connu pour activer SLC17A2 par les voies de détection des ions métalliques.

Nicotinic Acid

59-67-6sc-205768
sc-205768A
250 g
500 g
$61.00
$122.00
1
(1)

L'acide nicotinique, en agissant comme précurseur du NAD+, peut renforcer l'activité de SLC17A2 par le biais de réactions d'oxydoréduction et du métabolisme énergétique.